TALPHERA, INC. Accrued Liabilities, Current
TALPHERA, INC. (TLPH) had Accrued Liabilities, Current of $3.15 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-12
- 2026-06-30: Accrued Liabilities, Current $3.15M.
- 2026-03-31: Accrued Liabilities, Current $2.45M.
- 2025-12-31: Accrued Liabilities, Current $2.62M.
- 2025-09-30: Accrued Liabilities, Current $2.04M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $3.15M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $2.45M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $2.62M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $2.04M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $1.15M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $1.01M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $1.25M 10-K · filed 2026-03-23 | |
| 2024-09-30 | $1.64M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $1.74M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $1.34M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $2.44M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $1.79M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $1.85M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $1.42M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $2.53M 10-K · filed 2024-03-06 | $4.27M 10-K · filed 2023-03-31 |
| 2022-09-30 | $4.40M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $4.26M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $4.32M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $3.43M 8-K · filed 2023-08-01 | $6.52M 10-K · filed 2022-03-10 |
| 2021-09-30 | $5.33M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $3.98M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $3.25M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $5.04M 10-K · filed 2022-03-10 | $4.89M 10-K · filed 2021-03-15 |
| 2020-09-30 | $4.29M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $3.75M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $4.12M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $5.53M 10-K · filed 2021-03-15 | |
| 2019-09-30 | $4.91M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $4.28M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $3.58M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $4.54M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $3.62M 10-Q · filed 2018-11-05 | |
| 2018-06-30 | $2.55M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $2.21M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $3.54M 10-K · filed 2019-03-07 | |
| 2017-09-30 | $3.54M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $4.37M 10-Q · filed 2017-08-02 | |
| 2017-03-31 | $4.54M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $4.59M 10-K · filed 2018-03-09 | |
| 2016-09-30 | $4.14M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $2.91M 10-Q · filed 2016-07-29 | |
| 2016-03-31 | $2.44M 10-Q · filed 2016-05-02 | |
| 2015-12-31 | $3.96M 10-K · filed 2017-03-03 | |
| 2015-09-30 | $2.34M 10-Q · filed 2015-11-03 | |
| 2015-06-30 | $2.05M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $2.78M 10-Q · filed 2015-05-05 | |
| 2014-12-31 | $3.65M 10-K · filed 2016-03-07 | |
| 2014-09-30 | $2.04M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $2.96M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $1.90M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $3.90M 10-K · filed 2015-03-13 | |
| 2013-09-30 | $3.05M 10-Q · filed 2013-11-05 | |
| 2013-06-30 | $2.93M 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $3.38M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $4.65M 10-K · filed 2014-03-17 | |
| 2012-09-30 | $2.14M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $2.48M 10-Q · filed 2012-08-10 | |
| 2012-03-31 | $2.13M 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $2.51M 10-K · filed 2013-03-12 | |
| 2011-09-30 | $1.69M 10-Q · filed 2011-11-08 | |
| 2011-06-30 | $1.78M 10-Q · filed 2011-08-11 | |
| 2010-12-31 | $859.00K 10-K · filed 2012-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |